Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taron

Showing results (261-270 of 327) with videos related to

Pageof 33
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 28, 2011
Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology WorkshopIsabel Bover, Christian Rolfo, Eloisa Jantus-Lewintre, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|November 20, 2024
[Photon-Counting Detector CT: Advances and Clinical Applications in Cardiovascular Imaging]Muhammad Taha Hagar, Christopher L Schlett, Tim Oechsner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on SarcomaRegina Alemany, David S Moura, Andres Redondo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomasMiguel Taron, Yukito Ichinose, Rafael Rosell, et al.
Plos One|August 11, 2012
Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomesMarta Dueñas, Mirentxu Santos, Juan F Aranda, et al.
Frontiers in Immunology|May 17, 2018
MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple MyelomaAlessandra Zingoni, Elisabetta Vulpis, Francesca Cecere, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cellsMiguel A Molina-Vila, Jordi Bertran-Alamillo, Noemí Reguart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancerD Isla, C Sarries, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patientsR de las Peñas, M Sanchez-Ronco, V Alberola, et al.
Journal of the American Heart Association|November 26, 2025
Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With CancerGiselle Alexandra Suero-Abreu, Zsofia D Drobni, Carlos A Gongora, et al.
Pageof 33

Showing results (261-270 of 327) with videos related to

Sort By:
Pageof 33
Lung Cancer (Amsterdam, Netherlands)|May 28, 2011
Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology WorkshopIsabel Bover, Christian Rolfo, Eloisa Jantus-Lewintre, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|November 20, 2024
[Photon-Counting Detector CT: Advances and Clinical Applications in Cardiovascular Imaging]Muhammad Taha Hagar, Christopher L Schlett, Tim Oechsner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on SarcomaRegina Alemany, David S Moura, Andres Redondo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomasMiguel Taron, Yukito Ichinose, Rafael Rosell, et al.
Plos One|August 11, 2012
Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomesMarta Dueñas, Mirentxu Santos, Juan F Aranda, et al.
Frontiers in Immunology|May 17, 2018
MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple MyelomaAlessandra Zingoni, Elisabetta Vulpis, Francesca Cecere, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cellsMiguel A Molina-Vila, Jordi Bertran-Alamillo, Noemí Reguart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancerD Isla, C Sarries, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patientsR de las Peñas, M Sanchez-Ronco, V Alberola, et al.
Journal of the American Heart Association|November 26, 2025
Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With CancerGiselle Alexandra Suero-Abreu, Zsofia D Drobni, Carlos A Gongora, et al.
Pageof 33